Transdermal therapeutic system containing at least two opioids
DE102007020799A1
Transdermal therapeutic system with remifentanil
DE102005033680A1
Transdermal system for delivering tamsulosin, useful for treating prostatic hypertrophy, comprises backing layer and adhesive matrix that contains the active agent but no permeation enhancer
DE102005025187A1
applicator
DE102005020078A1
Device and set for implants
DE102004011686A1
Dermal or transdermal therapeutic system with matrix component of renewable tubing
EP1457233A1
Transdermal drug delivery system with mesh electrode
DE10305137A1
Transdermal therapeutic delivery systems with a butenolide
DE10251256A1
Transdermal drug delivery system for oxybutynin
EP1103260A2
Transdermal system for the administration of clonidine
US6521191B1
Permeation cell for in vitro determination of skin permeation of pharmaceutical drugs
US7115276B1
Patch with reduced cold flow
EP1079815A1
Timed-release transdermal systems containing an active ingredient
